European Wax Center Completes Sale in Take-Private Deal

European Wax Center Inc. completed the sale of the company and a change in control on May 8 2026, according to an 8-K filed with the SEC the same day.

The filing discloses entry into a material definitive agreement, termination of a prior material definitive agreement, completion of the disposition of assets, creation of a direct financial obligation, notice of delisting, material modification to rights of security holders, change in control of the registrant, departure and election of directors and principal officers, amendments to articles of incorporation or bylaws, and exhibits.

Item 2.01 states the acquisition or disposition closed on that date. Item 5.01 identifies the new controlling party and the mechanism that effected the change in control. Item 5.02 reports specific director and officer transitions tied to the transaction.

All outstanding public shares of European Wax Center Inc. (Nasdaq: EWCZ) are affected. The company, which operates a nationwide chain of franchised and company-owned waxing centers, will no longer trade publicly. The consideration and exact dollar value are contained in the exhibits filed with the 8-K.

The operational change converts the registrant from a Nasdaq-listed public company to a privately controlled entity. The prior state of independent public ownership and listing ends immediately upon closing. New board composition and principal officers take effect on the closing date of May 8 2026.

The company must now satisfy obligations under the new material agreements and the direct financial obligation created in Item 2.03.

Downstream, European Wax Center must file any remaining financial statements required under Item 9.01 within the SEC's standard deadlines for an 8-K. Nasdaq will proceed with the delisting process under Item 3.01 after the notice. The new controlling party assumes responsibility for all amended governing documents under Item 5.03.

Security holders receive the transaction consideration according to the modified rights outlined in Item 3.03. The terminated agreement in Item 1.02 ends all prior obligations to the former counterparty on the closing date.

This transaction marks the completion of the take-private process first announced in the company's prior SEC disclosures. The 8-K supplies the definitive record of the parties, closing timeline, board changes, and delisting notice required once the sale became effective.